Overview
Welcome to Dwaey, specifically on NEOCLAV 228.5mg/5ml Suspension/Powder for page.
This medicine contains an important and useful components, as it consists of Co-amoxiclav.
NEOCLAV 228.5mg/5ml is available in the market in concentration 228.5mg (200mg + 28.5mg)/5ml and in the form of Suspension/Powder for.
NEOPHARMA is the producer of NEOCLAV 228.5mg/5ml and it is imported from UAE, The most popular alternatives of NEOCLAV 228.5mg/5ml are listed downward .
Clavulanic acid has a high affinity for and binds to certain ?-lactamases that generally inactivate amoxicillin by hydrolyzing its ?-lactam ring. Combining clavulanate potassium with amoxicillin extends the antibacterial spectrum of amoxicillin to include many bacteria normally resistant to amoxicillin and other penicillins and cephalosporins.
History of allergy especially to cephalosporins, infectious mononucleosis, severe renal impairment. Lactation: Drug excreted in breast milk; use caution
Penicillin allergy.
Pregnancy category: B
Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.
Co-amoxiclav
Co-amoxiclav
Co-amoxiclav
Co-amoxiclav
Co-amoxiclav
Co-amoxiclav
Co-amoxiclav
Co-amoxiclav